Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Bactiguard Holding AB ( ($SE:BACTI.B) ) has shared an announcement.
Bactiguard Holding AB has appointed its Nomination Committee for the upcoming Annual General Meeting in 2026, scheduled for May 19 in Stockholm. The committee, comprising representatives from major shareholders, will propose candidates for the Board of Directors and auditors, as well as remuneration policies. This appointment is a routine part of Bactiguard’s governance structure, ensuring shareholder involvement in key decisions and maintaining transparency in its operations.
The most recent analyst rating on ($SE:BACTI.B) stock is a Hold with a SEK17.50 price target. To see the full list of analyst forecasts on Bactiguard Holding AB stock, see the SE:BACTI.B Stock Forecast page.
More about Bactiguard Holding AB
Bactiguard is a global MedTech company specializing in the development of safe and biocompatible technology aimed at preventing infections related to medical devices. Their technology, which utilizes an ultra-thin noble metal coating, is designed to prevent bacterial adhesion and biofilm formation. The company focuses on five key therapeutic areas: Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Bactiguard operates through partnerships with leading global MedTech companies and offers a portfolio of wound management products. Their solutions aim to reduce patient suffering, save lives, and combat antimicrobial resistance. Bactiguard is headquartered in Stockholm, listed on Nasdaq Stockholm, and is part of the Mid-Cap segment.
Average Trading Volume: 21,152
Technical Sentiment Signal: Sell
Current Market Cap: SEK578.2M
For an in-depth examination of BACTI.B stock, go to TipRanks’ Overview page.